1-15 of 22
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
CME/CESpotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD
Benjamin Korman, MD
Decoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment
CME/CEDecoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment
Praveen Akuthota, MD
Anisha Dua, MD, MPH
Michael E. Wechsler, MD, MMSc
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Silke R. Brix, MD, MRCP, SCPR
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
- advertisement
Incorporating Targeted Therapies in Treatment Planning for AAV
CME/CEIncorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
Abdul Abdellatif, MD, FASN
Richard Johnson, MD
What’s New About Gout? Rheumatology Perspective
MinuteCE®What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD
John K. Botson, MD, RPh
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®Treat or Refer: Who Is Responsible for Managing Gout?
John K. Botson, MD, RPh
Abdul Abdellatif, MD, FASN
What Are the Emerging Therapies for Managing Gout?
MinuteCE®What Are the Emerging Therapies for Managing Gout?
Richard Johnson, MD
John K. Botson, MD, RPh
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®Can You Manage Patients With Uncontrolled Gout More Effectively?
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
- advertisement
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
- MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®Center of the Target: Which Patients Are Most Likely to Develop Gout?
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
